Silo Pharma, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2018 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Silo Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q4 2024.
- Silo Pharma, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $82.7K, a 26.2% decline year-over-year.
- Silo Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $313K, a 39.3% increase year-over-year.
- Silo Pharma, Inc. annual Nonoperating Income (Expense) for 2024 was $313K, a 39.3% increase from 2023.
- Silo Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $225K.
- Silo Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$280K, a 104% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)